{"id":"W4402566053","doi":"10.1016/j.annonc.2024.08.1861","title":"1770P Safety, efficacy, and patient-reported outcomes (PROs) with vimseltinib in patients (pts) with tenosynovial giant cell tumor (TGCT) who received prior anti–colony-stimulating factor 1 (CSF1) therapy: Ongoing phase II study","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Musculoskeletal synovial abnormalities and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Surgery; Oncology; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008739333,0.0004765152,0.001070842,0.0001882548,0.0002298269,0.0007148175,0.0002901102,0.0005567277,0.001206156],"category_scores_gemma":[0.0008787451,0.0001706453,0.00121926,0.0002318031,0.0003223529,0.0006448043,0.0001868862,0.001204963,0.0002989789],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006941699,"about_ca_system_score_gemma":0.0005317091,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005153996,"about_ca_topic_score_gemma":0.001487335,"domain_scores_codex":[0.9997374,0.00009146673,0.00002242712,0.00004058672,0.00004710963,0.0000609727],"domain_scores_gemma":[0.9996572,0.00008265071,0.000130105,0.0000159042,0.00002565148,0.00008848846],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5869116,0.006480803,0.07978971,0.001527953,0.005646701,0.0005112829,0.0002401197,0.006215166,0.02653478,0.0006014038,0.004993419,0.2805472],"study_design_scores_gemma":[0.2438778,0.3883802,0.3187124,0.0003999243,0.008489632,0.002599357,0.0004455439,0.01068802,0.01413149,0.001236222,0.01086648,0.0001728627],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966024,0.00188962,0.00007748869,0.0001438453,0.00003091124,0.00006372916,0.0003434723,0.0000125106,0.0008360351],"genre_scores_gemma":[0.9978459,0.0005871061,0.0001283933,0.0001693622,0.000034652,0.00009692763,0.0006523721,0.000003026423,0.0004822923],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001206156,"threshold_uncertainty_score":0.005036592,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0370907144734042,"score_gpt":0.3505285809775074,"score_spread":0.3134378665041032,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}